Biomarin Pharmaceutical Inc banner

Biomarin Pharmaceutical Inc
NASDAQ:BMRN

Watchlist Manager
Biomarin Pharmaceutical Inc Logo
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Watchlist
Price: 53.24 USD -4% Market Closed
Market Cap: $10.2B

Intrinsic Value

The intrinsic value for Biomarin Pharmaceutical Inc (BMRN) under the Base Case is 101.31 USD. Compared with the current market price of 53.24 USD, the stock appears Undervalued by 47% .

Based on two methods:

Both DCF and multiples point to undervaluation.

BMRN Intrinsic Value
101.31 USD
Undervaluation 47%
Intrinsic Value
Price $53.24
Bear Case
Base Case
Bull Case
Monitor BMRN
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $81.05
Get notified when the price drops into your buy zone
Intrinsic Value $101.31
Margin of Safety 20% $81.05
Current Price $53.24
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about BMRN?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is BMRN valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Biomarin Pharmaceutical Inc.

Explain Valuation
Alternatives to BMRN

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

BMRN Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one BMRN stock?

The intrinsic value for Biomarin Pharmaceutical Inc (BMRN) under the Base Case is 101.31 USD.

Is BMRN stock undervalued or overvalued?

Compared with the current market price of 53.24 USD, the stock appears Undervalued by 47% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett